Information Letter on Vfend® 200 mg powder for solution for infusion (voriconazole): Temporary shortage
2012.03.12
Active substance: voriconazole
It is recommended to limit the use of the product to patients without alternative treatment options. A Rote-Hand-Brief with treatment recommendations has been circulated to treating physicians and pharmacies concerned.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN